Vimarsana
Biggest News Aggregation in the World

Page 8 - Rxsight Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rxsight Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rxsight Inc Today - Breaking & Trending Today

RxSight, Inc. (NASDAQ:RXST) Receives Consensus Recommendation of "Buy" from Analysts - Vimarsana News

RxSight, Inc. (NASDAQ:RXST) Receives Consensus Recommendation of "Buy" from Analysts

Shares of RxSight, Inc. (NASDAQ:RXST – Get Free Report) have received a consensus recommendation of “Buy” from the six research firms that are presently covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issued ratings on the stock in the […]

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance - Vimarsana News

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance

ALISO VIEJO, Calif., Jan. 07, 2024 -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today...

Head-To-Head Contrast: Strategic Global Investments (OTCMKTS:STBV) vs. RxSight (NASDAQ:RXST) - Vimarsana News

Head-To-Head Contrast: Strategic Global Investments (OTCMKTS:STBV) vs. RxSight (NASDAQ:RXST)

RxSight (NASDAQ:RXST – Get Free Report) and Strategic Global Investments (OTCMKTS:STBV – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, institutional ownership and earnings. Analyst Ratings This is a summary of current […]

RxSight Q4 Prelim Revenue Surges; Expects 2024 Revenue To Improve Above Estimates - Vimarsana News

RxSight Q4 Prelim Revenue Surges; Expects 2024 Revenue To Improve Above Estimates

RxSight, Inc. (RXST), ophthalmic medical devices provider, reported a surge in preliminary revenue for the fourth-quarter. For the fourth-quarter, RxSight expects to register revenue of around $28.

Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer - Vimarsana News

Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer

Massimo Calafiore begins as President and Chief Executive Officer, effective immediately Julie Andrews is appointed as Chief Financial Officer, assuming the role effective January 15, 2024 ...